Liquidity Analysis of Aarti Drugs Limited
Details
CLFIN035
7
2018-21
2022
YES
400
Aarti Drugs Limited
Pharmaceuticals & Biotech
India
Financial Analysis,Financial Analysis
Abstract
Two trainees from an investment bank, as a part of their training program, were planning to make a presentation on the liquidity position of Aarti Drugs Limited (ADL) for the financial years 2018-19 to 2020-21. ADL is a leading pharma company in India listed under the category of small caps segment in the Bombay Stock Exchange. The present case study provides scope to discuss the concept of liquidity analysis and process of analyzing and interpreting the liquidity position of a company using liquidity ratios.
Learning Objectives
The case is structured to achieve the following Learning Objectives:
- The concept of liquidity analysis
- The application of liquidity ratios
- The liquidity position of Aarti Drugs Limited
- The Cash Conversion Cycle (CCC) and its role in liquidity management
Keywords
Liquidity analysis; Short-term solvency; Current Assets; Current Liabilities; Liquidity Ratios; Current Ratio; Quick Ratio; Cash ratio; Aarti Drugs Limited
Related Case Studies
| Case Title | Details | Price | Add to Cart |
|---|---|---|---|
|
Case Title Indian Overseas Bank: Revival PlanCase Code: BSTR502 |
Details | 500 | Add to Cart |
|
Case Title Risk Management and Performance Analysis of HSBC GroupCase Code: FINC104 |
Details | 600 | Add to Cart |
|
Case Title Financial Statement Analysis of Unilever plcCase Code: FINC098 |
Details | 400 | Add to Cart |
|
Case Title Financial Statement Analysis of Ashok LeylandCase Code: FINC096 |
Details | 500 | Add to Cart |
|
Case Title Valuation of Ashok LeylandCase Code: FINC091 |
Details | 400 | Add to Cart |